Offer - Urjas Oil for just Rs 1 X
Fluvoxin 50 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Obsessive Compulsive Disorder.
Medical history of the patient along with age and gender determines the dosage of Fluvoxin 50 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The side effects typically associated with Fluvoxin 50 Tablet include Insomnia, Headache, Fatigue. Besides the aforementioned side effects, there are other adverse effects of Fluvoxin 50 Tablet as well, which are listed below. Normally, these side effects of Fluvoxin 50 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Fluvoxin 50 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. Further, the section on Fluvoxin 50 Tablet related warnings talks about Fluvoxin 50 Tablet's effects on the liver, heart and kidney.
Fluvoxin 50 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Fluvoxin 50 Tablet in conditions like Depression. The section on Fluvoxin 50 Tablet contraindications lists all such conditions.
Additionally, Fluvoxin 50 Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Fluvoxin 50 Tablet is considered not safe while driving, and is not addictive.
Fluvoxin 50 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Fluvoxin 50 Tablet safe for pregnant women?
Fluvoxin may have some side effects during pregnancy. Pregnant women should discontinue the use of Fluvoxin, and talk to their doctor, if they notice any discomfort.
Is the use of Fluvoxin 50 Tablet safe during breastfeeding?
Fluvoxin may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Fluvoxin 50 Tablet on the Kidneys?
Fluvoxin does not damage the kidneys.
What is the effect of Fluvoxin 50 Tablet on the Liver?
Side effects of Fluvoxin rarely affect the liver.
What is the effect of Fluvoxin 50 Tablet on the Heart?
Side effects of Fluvoxin rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Fluvoxin 50 Tablet unless your doctor advises you to do so -
Is this Fluvoxin 50 Tablet habit forming or addictive?
No, there is no any evidence that Fluvoxin 50 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Fluvoxin 50 Tablet, you should not drive or work on any heavy machine, as Fluvoxin 50 Tablet can make you drowsy.
Is it safe?
Yes, Fluvoxin 50 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, Fluvoxin 50 Tablet is useful in treating mental disorders.
Interaction between Food and Fluvoxin 50 Tablet
Taking Fluvoxin 50 Tablet with food does not cause any problems.
Interaction between Alcohol and Fluvoxin 50 Tablet
Taking alcohol with Fluvoxin 50 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Luvox® (Fluvoxamine Maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 41-42